Professional Documents
Culture Documents
Bpharm 6 Sem Clinical Pharmacotherapeutics 1 p5 3177 Summer 2019
Bpharm 6 Sem Clinical Pharmacotherapeutics 1 p5 3177 Summer 2019
com
NRT/KS/19/3177
B.Pharm. Sixth Semester (C.B.S.) Examination
CLINICAL PHARMACOTHERAPEUTICS—I
Paper—5
Time : Three Hours] [Maximum Marks : 80
N.B. :— (1) Question No. 1 is compulsory.
(2) Attempt any four questions out of remaining.
(3) All questions carry marks as indicated.
(4) Draw neat labeled diagram wherever necessary.
(g) Discuss the treatment available for systemic lupus erythematosis. 5×4=20
2. What are the causes responsible for neurodegeneration in Parkinson’s disease ? Explain the
pharmacotherapy of Parkinson’s. 15
3. Explain the pathological events in peptic ulcer. Discuss the pharmacological treatment of types
of peptic ulcers. 15
4. Differentiate acute and chronic renal failure. Explain the pathological events and treatment
options available for acute and chronic renal failure. 15
5. Discuss in detail the etiopathogenesis of cystic fibrosis. Explain the pharmacotherapy of cystic
fibrosis. 15
6. Discuss different mechanisms responsible for congestive heart failure. Explain secondary
complications and pharmacotherapy of it. 15
(b) Osteoarthritis
CLS—19910
http://www.rtmnuonline.com